CD8A and neoplasm: Following cross-presentation and costimulation primarily by cDC1 in secondary lymphoid organs, naïve CD8+ T cells become activated and migrate to tumor sites, where they directly eliminate tumor cells through perforin/granzyme-mediated or FAS/FASL-mediated cytotoxicity.